by
Psoriasis
@ Thu, 10 Jul 2008 22:00:03 -0500
Phase with treatment clinically plaque moderate one therapy given weeks data provided from 12 ... severe in ustekinumab study second meaningful double-blind, through showed the 3 placebo-controlled sustained, improvement psoriasis of a every to One-year
Phase with treatment clinically plaque moderate one therapy given weeks data provided from 12 ... severe in ustekinumab study second meaningful double-blind, through showed the 3 placebo-controlled sustained, improvement psoriasis of a every to One-year